© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
September 05, 2008
Low-density lipoprotein (LDL) cholesterol-lowering therapy decreases C-reactive protein (CRP) levels, but the importance of LDL cholesterol-independent effects is uncertain because of the variability in measuring LDL cholesterol and CRP levels in any individual patient. In this study, this variability was reduced by comparing average changes in LDL cholesterol and CRP levels after treatment with lipid-lowering therapy across different studies.
Aaron Kowalski, PhD: Connecting the Dots with the Type 1 Diabetes Index
Plaque Psoriasis Treated With Tildrakizumab Shown to be Effective in Real-World Settings
Predominantly Persistent IRF in nAMD Eyes Linked to Worse Long-Term Visual Acuity